CA2955456C - Identification de peptides immunogenes de classe ii du complexe majeur d'histocompatibilite pour une immunotherapie - Google Patents

Identification de peptides immunogenes de classe ii du complexe majeur d'histocompatibilite pour une immunotherapie

Info

Publication number
CA2955456C
CA2955456C CA2955456A CA2955456A CA2955456C CA 2955456 C CA2955456 C CA 2955456C CA 2955456 A CA2955456 A CA 2955456A CA 2955456 A CA2955456 A CA 2955456A CA 2955456 C CA2955456 C CA 2955456C
Authority
CA
Canada
Prior art keywords
cancer
peptide
peptides
fold
cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA2955456A
Other languages
English (en)
Other versions
CA2955456A1 (fr
Inventor
Gary K. Koski
Brian J. Czerniecki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority claimed from PCT/US2015/041034 external-priority patent/WO2016011432A2/fr
Publication of CA2955456A1 publication Critical patent/CA2955456A1/fr
Application granted granted Critical
Publication of CA2955456C publication Critical patent/CA2955456C/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

L'invention concerne des compositions, des méthodes et des vaccins qui peuvent stimuler le système immunitaire et qui peuvent être utilisés pour le traitement de tumeurs malignes associées à une surexpression de la protéine HER-3. Ces compositions comprennent des épitopes de la protéine HER-3.
CA2955456A 2014-07-17 2015-07-17 Identification de peptides immunogenes de classe ii du complexe majeur d'histocompatibilite pour une immunotherapie Active CA2955456C (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201462025681P 2014-07-17 2014-07-17
US62/025,681 2014-07-17
US201462076789P 2014-11-07 2014-11-07
US62/076,789 2014-11-07
PCT/US2015/041034 WO2016011432A2 (fr) 2014-07-17 2015-07-17 Identification de peptides immunogènes de classe ii du complexe majeur d'histocompatibilité pour une immunothérapie

Publications (2)

Publication Number Publication Date
CA2955456A1 CA2955456A1 (fr) 2016-01-21
CA2955456C true CA2955456C (fr) 2026-03-31

Family

ID=

Similar Documents

Publication Publication Date Title
ES2378264T3 (es) Péptido antigénico de unión a HLA-DR derivado de WT1
JP4591983B2 (ja) ペプチド
KR102308798B1 (ko) 다양한 암의 면역요법 치료에서의 사용을 위한 펩티드, 펩티드의 조합 및 골격
KR102049928B1 (ko) 효모-muc1 면역요법 조성물 및 그 용도
US20130129760A1 (en) Polypeptides
KR20180121530A (ko) 비소세포 폐암 및 기타 암에 대한 면역요법에서의 사용을 위한 펩티드 및 펩티드의 조합
US20210163573A1 (en) Identification of immunogenic mhc class ii peptides for immune-based therapy
CN109311955B (zh) 一种新的肿瘤特异性多肽及其应用
AU2015362469A1 (en) Tumor antigen peptide
EP1715042B1 (fr) Epitope/peptide reconnu par ctl specifique de ep-cam a restriction hla-a2402 et son utilisation
CA2955456C (fr) Identification de peptides immunogenes de classe ii du complexe majeur d'histocompatibilite pour une immunotherapie
WO2017014810A1 (fr) Identification de peptides immunogènes de classe ii du complexe majeur d'histocompatibilité pour une immunothérapie
JP5279063B2 (ja) Hla−a2拘束性抗原ペプチドおよびその用途
WO2019160099A1 (fr) Peptide antigénique de cancer
AU2017201075B2 (en) Identification of immunogenic MHC Class II peptides for immune-based therapy
CZ20004065A3 (cs) Peptidy
HK40002813A (en) Novel tumor-specific polypeptide and application thereof
HK40002813B (en) Novel tumor-specific polypeptide and application thereof
WO2011112599A2 (fr) Peptides pote immunogènes et leurs procédés d'utilisation